On August 30, 2023 Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, reported that it will webcast its presentations at five investor conferences in September. The presentations will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer, and Nate Hardy, Sana’s Chief Financial Officer (Press release, Sana Biotechnology, AUG 30, 2023, View Source [SID1234634778]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Steve Harr will present at Citi’s 18th Annual BioPharma Conference at 10:30 a.m. ET on Wednesday, September 6, 2023.
Steve Harr will present at the 2023 Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023.
Nate Hardy will present at the HC Wainwright 25th Annual Global Investment Conference at 10:00 a.m. ET on Monday, September 11, 2023.
Steve Harr will present at the Morgan Stanley 21st Annual Healthcare Conference at 1:35 p.m. ET on Tuesday, September 12, 2023.
Nate Hardy will present at the 2023 Cantor Global Healthcare Conference at 10:55 a.m. ET on Wednesday, September 27, 2023.
The webcasts will be accessible on the Investor Relations page of Sana’s website at View Source A replay of each presentation will be available at the same location for 30 days following the corresponding conference.